About this trial
this is an observational study for patients with non metastatic bladder cancer recieving local radical radiotherapy with curative intent recieving radical dose of radiotherapy with or without chemosensitizer
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Histologically confirmed urothelial carcinoma or variants; definitive intent radiotherapy
Disqualifiers
Palliative radiotherapy only; prior radical cystectomy; or incomplete follow-up data.
Trial population
Medical records of all cancer urinary bladder patients will be examined retrospectively. Histologically confirmed urothelial carcinoma or variants; definitive intent radiotherapy (≥50 Gy to bladder/pelvis); complete treatment records available.
Trial design
Case-only
Retrospective
Treatments tested in this trial
Radiotherapy followed by chemotherapy
Radiationit is observational study for patient recieved defentive radiotherapy
Treatment groups
Trial outcomes
Primary outcomes
overall survival, it is defined as time from initiation of treatment till death due to any cause or last date for follow up
bladder intact events free survival , which is the time from initiation of radical ttt till occurrence of bladder recurrence
disease free survival , it is time from starting radical ttt till occurrance of 1st recurrence or distant metastasis
Secondary outcomes
adverse events , it is treatment related toxicity and side effects
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: